Work

[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].

Year: 2011

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Shoji Nakamori, Wakio Endo, Hiroki Ozato, Takashi Shibata, Yutaka Takeda, Ken Tohno, Yasunori Hasuike, Seizo Masutani, Takashi Morimoto, Yuichirou Doki, Masaki Mori, Morito Monden

Institution: The University of Osaka

Language: Japanese

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2467783240

FWCI: 0.445

Cites:

Cited by: 3

Related to: 10